| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.050.166 |
| Chemical and physical data | |
| Formula | C8H10N4O2 |
| Molar mass | 194.194 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Enprofylline (3-propylxanthine) is a xanthine derivative used in the treatment of asthma, which acts as a bronchodilator. It acts primarily as a competitive nonselective phosphodiesterase inhibitor with relatively little activity as a nonselective adenosine receptor antagonist.
| PDE1 | |
|---|---|
| PDE2 | |
| PDE3 | |
| PDE4 |
|
| PDE5 | |
| PDE7 | |
| PDE9 | |
| PDE10 | |
| PDE11 | |
| Non-selective | |
| Unsorted | |
See also: Receptor/signaling modulators | |
| Receptor (ligands) |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (blockers) |
| ||||||||||
| Enzyme (inhibitors) |
| ||||||||||
| Others | |||||||||||
See also: Receptor/signaling modulators | |||||||||||